Methods and compositions for treating diabetes, metabolic syndrome and other conditions
US10098877B2 · kind B2 · utility
7Cited by
2References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 1, 2018 |
| Grant date | Oct 16, 2018 |
| Priority date | — |
| Expiry date | Feb 1, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceuticals compositions comprising the 2S, 4R, ketoconazole enantiomer or its pharmaceutically acceptable salts, hydrates, and solvates, that are substantially free of the 2R, 4S ketoconazole enantiomer are useful to reduce cortisol synthese and for the treatment of type 2 diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome, and other diseases and conditions, including but not limited to Cushing's Syndrome, depression, and glaucoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.